Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release
- PMID: 31965346
- DOI: 10.1007/s11095-019-2730-4
Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release
Abstract
Purpose: We describe the preparation of injectable polymeric paste (IPP) formulations for local and sustained release of drugs. Furthermore, we include the characterization and possible applications of such pastes. Particular attention is paid to characteristics relevant to the successful clinical formulation development, such as viscosity, injectability, degradation, drug release, sterilization, stability performance and pharmacokinetics.
Methods: Paste injectability was characterized using measured viscosity and the Hagen-Poiseuille equation to determine injection forces. Drug degradation, release and formulation stability experiments were performed in vitro and drug levels were quantified using HPLC-UV methods. Pharmacokinetic evaluation of sustained-release lidocaine IPPs used five groups of six rats receiving increasing doses subcutaneously. An anti-cancer formulation was evaluated in a subcutaneous tumor xenograft mouse model.
Results: The viscosity and injectability of IPPs could be controlled by changing the polymeric composition. IPPs demonstrated good long-term stability and tunable drug-release with low systemic exposure in vivo in rats. Preliminary data in a subcutaneous tumor model points to a sustained anticancer effect.
Conclusions: These IPPs are tunable platforms for local and sustained delivery of drugs and have potential for further clinical development to treat a number of diseases.
Keywords: cancer; local treatment; pain; polymer; sustained-release.
Similar articles
-
Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.Artif Cells Nanomed Biotechnol. 2017 Aug;45(5):944-954. doi: 10.1080/21691401.2016.1196457. Epub 2016 Jun 21. Artif Cells Nanomed Biotechnol. 2017. PMID: 27327352
-
Miniaturized screening and performance prediction of tailored subcutaneous extended-release formulations for preclinical in vivo studies.Eur J Pharm Sci. 2024 May 1;196:106733. doi: 10.1016/j.ejps.2024.106733. Epub 2024 Feb 24. Eur J Pharm Sci. 2024. PMID: 38408709
-
A polymeric paste-drug formulation for intratumoral treatment of prostate cancer.Prostate Cancer Prostatic Dis. 2020 Jun;23(2):324-332. doi: 10.1038/s41391-019-0190-x. Epub 2019 Nov 25. Prostate Cancer Prostatic Dis. 2020. PMID: 31767941
-
Liquid jet breakup: A new method for the preparation of poly lactic-co-glycolic acid microspheres.Eur J Pharm Biopharm. 2019 Apr;137:140-147. doi: 10.1016/j.ejpb.2019.02.021. Epub 2019 Feb 25. Eur J Pharm Biopharm. 2019. PMID: 30818010
-
Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.Pharm Nanotechnol. 2017;5(1):3-23. doi: 10.2174/2211738505666161230110108. Pharm Nanotechnol. 2017. PMID: 28948907 Review.
Cited by
-
SARS-CoV-2 and its new variants: a comprehensive review on nanotechnological application insights into potential approaches.Appl Nanosci. 2023;13(1):65-93. doi: 10.1007/s13204-021-01900-w. Epub 2021 Jun 10. Appl Nanosci. 2023. PMID: 34131555 Free PMC article. Review.
-
Antiviral therapies: advances and perspectives.Fundam Clin Pharmacol. 2021 Apr;35(2):305-320. doi: 10.1111/fcp.12609. Epub 2020 Nov 8. Fundam Clin Pharmacol. 2021. PMID: 33011993 Free PMC article. Review.
-
On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges.Nanomaterials (Basel). 2020 Apr 28;10(5):852. doi: 10.3390/nano10050852. Nanomaterials (Basel). 2020. PMID: 32354113 Free PMC article. Review.
-
A phase 1 study of an injectable lidocaine paste for spermatic cord block in men with chronic scrotal content pain.Can Urol Assoc J. 2023 Jul;17(7):E194-E201. doi: 10.5489/cuaj.8222. Can Urol Assoc J. 2023. PMID: 37068147 Free PMC article.
-
Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics.J Nanobiotechnology. 2025 Feb 1;23(1):72. doi: 10.1186/s12951-025-03141-3. J Nanobiotechnology. 2025. PMID: 39893419 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources